73 / 112
71
WFSBP 2015
Wednesday, 17 June 2015
|
Scientific Programme
P-18
Poster Presentation
12:45–14:15
Muses Foyer
Dementia/Pregnancy/Psychoneuroimmunology
Chair:
Angelos Halaris, USA
Co-Chair: Maria Anagnostouli, Greece
P-18-001
Thalamic shape and cognitive performance in amnestic
mild cognitive impairment
Changtae Hahn, Republic of Korea
C.-U. Lee
P-18-002
An exploratory study to reveal the neural basis of visual
cognitive dysfunction in Alzheimer‘s disease
Taku Yoshida, Japan
T. Mori, N. Sonobe, H. Shimizu, T. Matsumoto, S.-i. Ueno
P-18-003
Platelet APP ratio in AD patients treated with donepezil
Jessyka Maria de França Bram, Brazil
T. Alves Sarno, H. Passarelli Giroud Joaquim, L. Leme Talib,
S. R. Hototian, W. Farid Gattaz, O. Vicente Forlenza
P-18-004
Prevalence of alcohol, tobacco and psychoactive substances
in a cohort of 700 pregnant women–GTOX study: Prelim-
inary results
Sandrine Lamy, France
H. Delavenne, E. Houivet, J. Benichou, S. Marret, F. Thibaut
P-18-005
Hair steroid analysis in postpartum mothers: An increased
ratio of hair cortisol/hair cortisone is associated with post-
partum depression
Thorsten Mikoteit, Switzerland
S. Brand, G. Meinlschmidt, N. Buerki, I. Hoesli, E. Hols-
boer-Trachsler
P-18-006
Alterations of the cortisol and dehydroepiandrosterone in
perinatal depression
Ho-Suk Suh, Republic of Korea
R.-S. Ahn, C.-H. Kim, K.-S. Lee
P-18-007
Biochemical markers and symptoms of depression in post-
partum women
Maria Radziwon-Zaleska, Poland
E. Drozdowicz, J. Skrzeszewski, M. Wielgos, M. Skalski,
R. Rodzoch
P-18-008
Postpartum depression is associated with insomnia, de-
creased total sleep time and a lack in NREM S3 sleep du-
ration
Thorsten Mikoteit, Switzerland
S. Brand, N. Buerki, I. Hoesli, E. Holsboer-Trachsler
P-18-009
Risks of antidepressants during pregnancy–a review
Margarida Viana Almeida Coelho, Portugal
A. R. Carvalho
P-18-010
Treating perinatal depression in low and middle-income
countries: A systematic review
Amy Gajaria, Canada
T. da Silva, A. Ravindran
P-18-011
Antipsychotics in pregnancy: Safety and indications
Ana Rita Carvalho, Portugal
M. Coelho, R. Navarro
P-18-013
Cytokine profiles in ultra-high risk and first-episode schizo
phrenia and the effects of aripiprazole treatment
Yi-Ling Chien, Taiwan
C.-M. Liu, C.-C. Liu, H.-G. Hwu
P-18-014
Suicidal patients are deficient in vitamin D, associated with
a pro-inflammatory status in the blood
Cécile Grudet, Sweden
J. Malm, Å. Westrin, L. Brundin
P-18-015
Altered immune repertoire in major depression
Kostas Patas, Germany
A. Willing, A. Agorastos, C. Demiralay, K. Wiedemann, S. Gold
P-18-016
Reduced frequency of blood CD8+ T lymphocytes express-
ing proinflammatory cytokines in mesial temporal lobe
epilepsy patients
Daniela Rosa, Brazil
V. Rezende, B. Costa, M. Schutze, F. Mudado, L. Magno,
M. Vasconcelos, D. Miranda, M. Romano-Silva
P-18-018
Proinflammatory cytokines and oxidative stress reduces
the dopamine precursor tyrosine uptake in human skin
fibroblasts: Role of antioxidants as adjuvants
Ravi Vumma, Sweden
J. Johansson, N. Venizelos
P-18-019
Olfactory cravings and cytokine-mediated nociception in
vulnerability to substance abuse
Tatyana Nevidimova, Russia
E. Batukhtina, N. Bokhan
P-18-021
Biomarkers of brain insulin resistance and neuroimaging
correlates in early AD
Dimitrios Kapogiannis, USA
A. Willette, R. Mullins, M. Mustapic, E. Eitan, M. Mattson,
E. Goetzl